New Trial Open for Patients With Post-Thrombotic Syndrome
July 28, 2020 | 4 min. to read
Vascular Surgeon Joseph R. Schneider, MD, PhD, and Interventional Radiologist Kush R. Desai, MD, are seeking to enroll patients in Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (C-TRACT), a large, randomized controlled trial of new treatments for vein damage caused by chronic deep vein thrombosis (DVT).
The Northwestern Medicine study sites are Central DuPage Hospital, Delnor Hospital and Northwestern Memorial Hospital. The study is sponsored by the National Institutes of Health. Eligible patients with established moderate to severe Post-Thrombotic Syndrome will be randomized to either endovascular therapy (EVT) or No-EVT treatment groups. All study patients in both groups will receive modern, active treatment for their leg problem and be monitored closely for two years. Patients also will receive a $100 stipend at follow-up visits and compression garments. Patients receiving EVT will be treated with new image-guided procedures. This trial aims to find the most effective treatment to improve patients’ symptoms and quality of life. Please refer patients who meet these criteria: • Age 18 and older • Daily leg swelling or aching of at least moderate severity, or presence of a venous leg ulcer • Have a history of previous DVT (suspected or documented)